Literature DB >> 31325822

Smoking relapse risk is increased among individuals in recovery.

Amanda J Quisenberry1, Jami Pittman2, Renee D Goodwin3, Warren K Bickel4, Giordano D'Urso5, Christine E Sheffer6.   

Abstract

BACKGROUND: The prevalence of cigarette smoking among individuals with a history of substance use disorders (SUDs) remains up to four times higher than those without a history of SUDs. More than half of individuals who attain sustained remission from SUDs will die of tobacco-related diseases. The aim of this secondary data analysis was to compare the risk for smoking relapse among smokers with no history of SUDs and smokers in recovery from SUDs after multi-component, cognitive-behavioral treatment for tobacco dependence.
METHODS: Participants were randomized to receive 6 sessions of multicomponent cognitive-behavioral therapy (adapted for lower socioeconomic groups or standard), 8 weeks of nicotine patches, and were followed for 6 months in the parent randomized clinical trial. Participants passed a urine drug test prior to enrollment. Recovery was assessed at baseline by self-report to the question, "Do consider yourself in recovery from drugs or alcohol?" Relapse was defined as any smoking for 7 consecutive days.
RESULTS: Participants were primarily lower SES and identified as racial and/or ethnic minorities. Cox proportional hazards models revealed that the risk of smoking relapse following tobacco dependence treatment was greater among smokers in long-term (HR: 1.44; 95% CI: 1.01, 2.05) and short-term (HR: 1.98; 95% CI: 1.30, 3.03) recovery than for smokers with no history of SUDs.
CONCLUSIONS: Our findings indicate that smokers in recovery from SUDs have 1.5-2 times the risk of relapse than smokers with no history of SUDs. More effective relapse prevention interventions are needed for this vulnerable, high-risk group of smokers.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Recovery; Relapse risk; Smoking cessation; Substance use disorders; Tobacco dependence treatment

Mesh:

Year:  2019        PMID: 31325822      PMCID: PMC6685745          DOI: 10.1016/j.drugalcdep.2019.07.001

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  94 in total

1.  Poverty and health: the mediating role of perceived discrimination.

Authors:  Thomas E Fuller-Rowell; Gary W Evans; Anthony D Ong
Journal:  Psychol Sci       Date:  2012-06-14

2.  Do daily interactive voice response reports of smoking behavior correspond with retrospective reports?

Authors:  Benjamin A Toll; Ned L Cooney; Sherry A McKee; Stephanie S O'Malley
Journal:  Psychol Addict Behav       Date:  2005-09

3.  Health disparities across the lifespan: meaning, methods, and mechanisms.

Authors:  Nancy E Adler; Judith Stewart
Journal:  Ann N Y Acad Sci       Date:  2010-02       Impact factor: 5.691

4.  Trends in Daily Cannabis Use Among Cigarette Smokers: United States, 2002-2014.

Authors:  Renee D Goodwin; Lauren R Pacek; Jan Copeland; Scott J Moeller; Lisa Dierker; Andrea Weinberger; Misato Gbedemah; Michael J Zvolensky; Melanie M Wall; Deborah S Hasin
Journal:  Am J Public Health       Date:  2017-11-21       Impact factor: 9.308

5.  Alexithymia, emotional dysregulation, and recovery from alcoholism: therapeutic response to assessment of mood.

Authors:  Amy R Krentzman; Margaret M Higgins; Karen M Staller; Emily S Klatt
Journal:  Qual Health Res       Date:  2015-03-25

6.  Differential effects of perceived discrimination on the diurnal cortisol rhythm of African Americans and Whites.

Authors:  Thomas E Fuller-Rowell; Stacey N Doan; Jacquelynne S Eccles
Journal:  Psychoneuroendocrinology       Date:  2012-01       Impact factor: 4.905

7.  The Social Readjustment Rating Scale.

Authors:  T H Holmes; R H Rahe
Journal:  J Psychosom Res       Date:  1967-08       Impact factor: 3.006

8.  The relationship between tobacco use, substance-use disorders and mental health: results from the National Survey of Mental Health and Well-being.

Authors:  L Degenhardt; W Hall
Journal:  Nicotine Tob Res       Date:  2001-08       Impact factor: 4.244

9.  Mortality following inpatient addictions treatment. Role of tobacco use in a community-based cohort.

Authors:  R D Hurt; K P Offord; I T Croghan; L Gomez-Dahl; T E Kottke; R M Morse; L J Melton
Journal:  JAMA       Date:  1996-04-10       Impact factor: 56.272

Review 10.  Neurobiological substrates for the dark side of compulsivity in addiction.

Authors:  George F Koob
Journal:  Neuropharmacology       Date:  2008-08-07       Impact factor: 5.250

View more
  3 in total

1.  Effects of ethanol, naltrexone, nicotine and varenicline in an ethanol and nicotine co-use model in Sprague-Dawley rats.

Authors:  Cassie M Chandler; Sarah E Maggio; Hui Peng; Kimberly Nixon; Michael T Bardo
Journal:  Drug Alcohol Depend       Date:  2020-04-25       Impact factor: 4.492

2.  The phenotype of recovery V: Does delay discounting predict the perceived risk of relapse among individuals in recovery from alcohol and drug use disorders.

Authors:  Jamie K Turner; Liqa N Athamneh; Julia C Basso; Warren K Bickel
Journal:  Alcohol Clin Exp Res       Date:  2021-04-05       Impact factor: 3.455

3.  Effectiveness of an interactive web-based health program for adults: a study protocol for three concurrent controlled-randomized trials (EVA-TK-Coach).

Authors:  Iris Tinsel; Gloria Metzner; Christian Schlett; Matthias Sehlbrede; Martina Bischoff; Robin Anger; Judith Brame; Daniel König; Ramona Wurst; Reinhard Fuchs; Peter Lindinger; Rainer Bredenkamp; Erik Farin-Glattacker
Journal:  Trials       Date:  2021-08-10       Impact factor: 2.279

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.